Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −15,416 4,584
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −78,125 45,875
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −49,479 75,521
2020-05-19 BENZENO SHARON Chief Business Development Off Option exercise · Common Stock (Right to Buy) −25,000 50,000
2020-05-19 ROBINS HARLAN S Chief Scientific Officer Sale −38,628 $40.11 $1.5M 32,051
2020-05-19 Cohen Chad M Chief Financial Officer Option exercise +30,000 $4.07 $122K 31,000
2020-05-19 Cohen Chad M Chief Financial Officer Option exercise +20,000 $6.32 $126K 51,000
2020-05-19 Cohen Chad M Chief Financial Officer Sale −50,000 $40.00 $2.0M 1,000
2020-05-19 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right To Buy) −20,000 700,000
2020-05-19 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −30,000 0
2020-05-19 DOBMEIER ERIC Director Option exercise +5,000 $6.32 $32K 5,000
2020-05-19 DOBMEIER ERIC Director Sale −5,000 $40.00 $200K 0
2020-05-19 DOBMEIER ERIC Director Option exercise · Stock Option (Right to Buy) −5,000 70,000
2020-05-18 ROBINS HARLAN S Chief Scientific Officer Option exercise +11,100 $6.32 $70K 81,779
2020-05-18 ROBINS HARLAN S Chief Scientific Officer Sale −600 $38.67 $23K 81,179
2020-05-18 ROBINS HARLAN S Chief Scientific Officer Sale −10,500 $39.36 $413K 70,679
2020-05-18 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −11,100 433,500
2020-05-15 HERSHBERG ROBERT Director Option exercise +2,000 $0.45 $900 2,000
2020-05-15 HERSHBERG ROBERT Director Sale −1,202 $34.14 $41K 798
2020-05-15 HERSHBERG ROBERT Director Sale −400 $35.23 $14K 398

Page 105 of 120 · 2,386 trades